Records 1 - 3
| Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
Oncology 2020 Jun 1-6.
Zhou Jing, Zhao Zhengyi, Zhang Yuzi, Bao Celimuge, Cui Longgang, Cai Shangli, Bai Yuezong, Shen Lin, Zhang Xiaoti
| Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
BMC cancer 2018 Sep 18 (1): 926.
Hoyer Juliane, Vasileiou Georgia, Uebe Steffen, Wunderle Marius, Kraus Cornelia, Fasching Peter A, Thiel Christian T, Hartmann Arndt, Beckmann Matthias W, Lux Michael P, Reis And
| A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.
Breast cancer research and treatment 2013 Nov 142 (2): 389-98.
Vinayak Shaveta, Schwartz Erich J, Jensen Kristin, Lipson Jafi, Alli Elizabeth, McPherson Lisa, Fernandez Adrian M, Sharma Vandana B, Staton Ashley, Mills Meredith A, Schackmann Elizabeth A, Telli Melinda L, Kardashian Ani, Ford James M, Kurian Allison